AI Terminal
REVOLUTION BEAUTY GROUP PLC
Report Publication Announcement • Jan 24, 2024
7881_rns_2024-01-24_9a450242-dab0-44a9-a304-6828dc1f1234.html
Report Publication Announcement
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 6764A
Revolution Beauty Group PLC
24 January 2024
24 January 2024
Revolution Beauty Group plc
("Revolution Beauty", the "Group", or the "Company")
Notice of Capital Markets Event
Revolution Beauty (AIM: REVB), the multi-channel mass beauty innovator, will hold a Capital Markets Event for institutional investors and sell-side analysts in London on Thursday, 8 February 2024.
The event will set out the Group's strategy to target the significant and compelling growth opportunities in its large and attractive global beauty markets. It will include presentations from Lauren Brindley, CEO, Neil Catto, CFO, Alison Hollingsworth, CMO and Stephen Vanoli, COO.
If you would like to attend, please email [email protected]. A recording will be made available on the Investor Relations section of the Group's website following the event.
For further information please contact:
Investor Relations
Lauren Brindley, CEO
Neil Catto, CFO
Joint Corporate Brokers
Liberum (NOMAD): Edward Thomas / Dru Danford / John More
Tel: +44 (0) 203 100 2222
Zeus: Nick Cowles / Jamie Peel / Jordan Warburton
Tel: +44 (0) 161 831 1512
Media enquiries
Headland Consultancy: Matt Denham / Will Smith / Antonia Pollock
Tel: +44 (0)20 3805 4822
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCUOVBRSVUAUAR